Publications by authors named "S Armand-Branger"

Adverse drug reactions (ADRs) are a major public health issue, especially when it comes to the elderly. Potentially inappropriate prescribing (PIP) are one of the causes of ADRs in older people. A PIP can be defined as a prescription for which the benefit/risk ratio is unfavourable compared to other therapeutic alternatives.

View Article and Find Full Text PDF
Article Synopsis
  • Anticholinergic properties are key in managing mental health conditions but can lead to adverse effects, including cognitive deficits and physical symptoms like dry mouth and constipation.
  • Anticholinergic drugs, often mistakenly categorized, mainly act as antagonists to the parasympathetic nervous system; particularly common in certain antipsychotics and tricyclic antidepressants.
  • Various anticholinergic burden scales have emerged to assess side effects, with three main scales (ADS, ARS, ACB) widely used in clinical practice, highlighting the need for awareness of these effects in treatment, especially in elderly patients and those on multiple medications.
View Article and Find Full Text PDF

Introduction: This paper presents a survey conducted on a population of multi-handicapped patients and autistic adults hospitalised long term in the Paul Guiraud mental health Hospital in Villejuif France.

Objective: The aim of the survey is to deepen the knowledge of the treatments for this specific population.

Methods: A preliminary medical investigation was conducted on the population in order to target different groups of patients.

View Article and Find Full Text PDF

Objectives: Postpartum anaemia is a very frequent pathology concerning from 4% to 27% of patients. The purpose of this study was to estimate clinical practice in front of acute postpartum anaemia and to value a new treatment: intravenous iron.

Patients And Methods: Retrospective study over a period of 2 years (April 2001-March 2003) realised in the Department of Gynaecology and Obstetrics of Belfort Regional Hospital.

View Article and Find Full Text PDF

Trimeprazine (TPZ) has been marketed in France since 1959, as tablets and solution containing respectively 5 mg and 40 mg/ml. TPZ is a phenothiazine derivative with known antihistaminic and sedative effects. The first approved indication for TPZ is in the treatment of allergy.

View Article and Find Full Text PDF